EXACT Therapeutics

Norway - OsloBiotechnology2 H-1B visas (FY2023)

Focus: EXACT Therapeutics is a newly founded (2024) Norwegian biotech company pioneering ultrasound-enhanced drug delivery technology across oncology, immunology, gastroenterology, and infectious diseases. The company is publicly listed but remains in early-stage development with no commercial products.

Oncology Immunology Gastroenterology Infectious Diseases

Profile data last refreshed 2d ago · AI intelligence enriched 2w ago

Funding Stage

PUBLIC

Open Jobs

About EXACT Therapeutics

AI assessmentNot Hiring

No open roles listed right now. Follow EXACT Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthSolid

Pipeline

Early-stage

46 total

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

Blood and Stool Sample Collection in Subjects With a Diagnosis of Colorectal Cancer or Colorectal Le

Colorectal Cancer

N/A

Clinical Trials (1)

NCT03789162Blood and Stool Sample Collection in Subjects With a Diagnosis of Colorectal Cancer or Colorectal Lesion: Act Fast

N/A

Help build intelligence for EXACT Therapeutics

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Cutting-edge platform technology (ultrasound-mediated drug delivery) with potential to unlock new therapeutic modalities across multiple disease areas
Public company status provides liquidity and potential equity upside despite pre-revenue stage
Diversified pipeline spanning oncology (pancreatic cancer, prostate cancer) and non-oncology indications suggests multiple shots on goal

Watch Out For

Extremely early-stage with only 1 Phase 2 program (Acoustic Cluster Therapy) and 1 Phase 1 program; no marketed products or revenue
Zero active job openings despite public status signals minimal near-term hiring; founded in 2024 with no disclosed employee count or funding details creates visibility risk

Generated by Claude from EXACT Therapeutics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

Cologuard

Colon Cancer

N/A

Clinical Trials (1)

NCT04124406Voyage: Real-World Impact of the Multi-target Stool DNA Test on CRC Screening and Mortality

N/A

Blood Sample Collection

Lung Cancer (Diagnosis)

N/A

Clinical Trials (1)

NCT03633006Blood Sample Collection in Subjects With Pulmonary Nodules or CT Suspicion of Lung Cancer or Pathologically Diagnosed Lung Cancer

N/A

Biopsy

Barrett Esophagus

N/A

Clinical Trials (1)

NCT02560623A Minimally-Invasive Sponge on a String Device for Screening for Barrett's Esophagus

N/A

Blood Sample Collection

Hematologic Malignancy

N/A

Clinical Trials (1)

NCT03727009Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Hematologic Malignancies

N/A

Stool Sample Collection Kit

Colorectal Neoplasms

N/A

Clinical Trials (1)

NCT02503631Stool Sample Collection Protocol for Development of Screening Test for Colorectal Cancer and Other Digestive Tract Cancers

N/A

Blood Sample Collection

Colo-rectal Cancer

N/A

Clinical Trials (1)

NCT03741166Blood Collection Sub-Study for CRC Screening in Individuals 45-49 at Average Risk for CRC.

N/A

Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical

Colorectal Neoplasms

N/A

Clinical Trials (1)

NCT01260168Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies

N/A

Testicular Evaluation of Azoospermia Using Micro-Ultrasound

Azoospermia

N/A

Clinical Trials (1)

NCT06941922Testicular Evaluation of Azoospermia Using Micro-Ultrasound

N/A

Exact Sciences Multicancer Early Detection

Cancer

N/A

Clinical Trials (1)

NCT06589310Falcon Real World Evidence Registry

N/A

Digital Image Analysis

Prostate Carcinoma

N/A

Clinical Trials (1)

NCT04299620Micro-Ultrasound for the Detection and Localization of Prostate Cancer Tumors in Patients Undergoing Radical Prostatectomy

N/A

Blood Sample Collection

Healthy

N/A

Clinical Trials (1)

NCT03628638Blood Sample Collection in Subjects Participating in a Lung Cancer Screening Program

N/A

Detecting Cancers Earlier Through Elective Plasma-based CancerSEEK Testing

Early Cancer Detection

N/A

Clinical Trials (1)

NCT04213326Detecting Cancers Earlier Through Elective Plasma-based CancerSEEK Testing

N/A

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous P

Colorectal Neoplasms

N/A

Clinical Trials (1)

NCT01397747Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

N/A

High-resolution ultrasound guided prostate biopsy

Prostatic Neoplasms

N/A

Clinical Trials (1)

NCT02079025Multi-Center Trial of High-resolution Transrectal Ultrasound Versus Standard Low-resolution Transrectal Ultrasound for the Identification of Clinically Significant Prostate Cancer

N/A

Exact CRC Screening Test: Stool Sample Collection Study to Support Assay Validation Testing

Colorectal Neoplasms

N/A

Clinical Trials (1)

NCT01600209Exact CRC Screening Test: Stool Sample Collection Study to Support Assay Validation Testing

N/A

Endometrial Cancer Vaginal Fluid Specimen Collection Study

Abnormal Uterine Bleeding (AUB)

N/A

Clinical Trials (1)

NCT07544680Endometrial Cancer Vaginal Fluid Specimen Collection Study

N/A

Stool Collection Kit

Inflammatory Bowel Disease

N/A

Clinical Trials (1)

NCT02503696Sample Collection Study to Evaluate DNA Markers in Subjects With Inflammatory Bowel Disease (IBD)

N/A

Biospecimen Collection

Colorectal Carcinoma

N/A

Clinical Trials (1)

NCT05410977Collecting Blood and Stool Samples to Detect Colorectal Cancer or Advanced Neoplasia in Lynch Syndrome Patients

N/A

SARS-CoV-2

COVID-19

N/A

Clinical Trials (1)

NCT04395391Home Usability Study of the SARS-CoV-2 (COVID-19) Test

N/A

Micro-ultrasound targeted biopsy

Prostate Cancer

N/A

Clinical Trials (1)

NCT03762616Urology San Antonio MRI/MicroUS Comparison

N/A

Brief Video

Colorectal Cancer

N/A

Clinical Trials (1)

NCT05246839Informed Choice - Compass

N/A

A screening device for the detection of colorectal and other aerodigestive tract cancers

Colorectal Cancer

N/A

Clinical Trials (1)

NCT06294873Stool Sample Collection Study

N/A

Blood Sample Collection

Melanoma

N/A

Clinical Trials (1)

NCT03727087Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Melanoma

N/A

mt-sDNA 2.0 screening test

Colorectal Cancer

N/A

Clinical Trials (1)

NCT04144738Clinical Validation of An Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, for Colorectal Cancer Screening "BLUE-C"

N/A

Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease

Inflammatory Bowel Disease (IBD)

N/A

Clinical Trials (1)

NCT01819766Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease

N/A

HR-TRUS

Prostate Cancer

N/A

Clinical Trials (1)

NCT03679819Single-center Trial for the Validation of High-resolution Transrectal Ultrasound (Exact Imaging Scanner ExactVu) for the Detection of Prostate Cancer

N/A

MRD

Colorectal Cancer

N/A

Clinical Trials (1)

NCT05210283CORRECT Study of Minimal Residual Disease Detection in Colorectal Cancer

N/A

ctDNA MRD test

Breast Cancer

N/A

Clinical Trials (1)

NCT06401421EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)

N/A

Blood Sample Collection

Breast Cancer

N/A

Clinical Trials (1)

NCT03662204Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors

N/A

6 month, prospective, interventional single-arm safety and effectiveness study

Prostate Cancer (Adenocarcinoma)

N/A

Clinical Trials (1)

NCT07339943Micro-ultrasound-Guided Focal Laser Ablation for Intermediate-Risk Prostate Cancer: Safety & Effectiveness

N/A

Study CT/MRI Imaging

Hepatocellular Carcinoma

N/A

Clinical Trials (1)

NCT05064553ALTUS: Performance of a Multi- Target Hepatocellular Carcinoma (HCC) Test in Subjects With Increased Risk

N/A

Cologuard

Colorectal Cancer Screening

N/A

Clinical Trials (1)

NCT02419716A Study of Cologuard™ in an Average Risk Population Assessing a Three Year Test Interval

N/A

De-escalation

Breast Cancer

N/A

Clinical Trials (1)

NCT05634889The T-REX Trial: Tailored Regional External Beam Radiotherapy in Clinically Node-negative Breast Cancer Patients With 1-2 Sentinel Node Macrometastases.

N/A

Blood and Stool Sample Collection in Subjects Participating in Colorectal Cancer Screening: Act Bold

Colorectal Cancer

N/A

Clinical Trials (1)

NCT03821948Blood and Stool Sample Collection in Subjects Participating in Colorectal Cancer Screening: Act Bold

N/A

Microultrasonography Targeted Biopsy

Prostate Cancer

N/A

Clinical Trials (1)

NCT05220501Optimization of Prostate Biopsy - Micro-Ultrasound Versus MRI

N/A

Cologuard

Colorectal Cancer

N/A

Clinical Trials (1)

NCT03705013Observational Study of Sub-populations From Cologuard Post-Approval Study (2014-01)

N/A

Blood Sample Collection

Colorectal Cancer

N/A

Clinical Trials (1)

NCT04144751Blood Collection Sub-Study of Exact Sciences Protocol 2019-01: "Clinical Validation of an Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, For Colorectal Cancer Screening BLUE-C"

N/A

Blood Sample Collection

Hepatocellular Carcinoma

N/A

Clinical Trials (1)

NCT03628651Blood Sample Collection to Evaluate Biomarkers for Hepatocellular Carcinoma

N/A

Stool Sample Collection

Colorectal Cancer

N/A

Clinical Trials (1)

NCT04473625Stool Collection Sub-Study of Exact Sciences Protocol 2018-01

N/A

Ultrasound guided prostate exam using SOC ultrasound system

Prostate Cancer

N/A

Clinical Trials (1)

NCT03035487Urology of Virginia Case Series

N/A

mt-sDNA screening test

Colorectal Cancer

N/A

Clinical Trials (1)

NCT03728348An Evaluation of a Multi-target Stool DNA (Mt-sDNA) Test, Cologuard, for CRC Screening in Individuals Aged 45-49 and at Average Risk for Development of Colorectal Cancer: Act Now

N/A

20 uL/kg PS101

Solid Tumor

PHASE_1

Clinical Trials (1)

NCT04021277PS101-mediated ACT With Chemotherapy in Liver Metastases From Cancer of Gastrointestinal Origin

Phase 1

Acoustic Cluster Therapy

Locally Advanced Pancreatic Adenocarcinoma

PHASE_2

Clinical Trials (1)

NCT06850623Acoustic Cluster Therapy (ACT) With Chemotherapy for the Treatment of Locally Advanced Pancreatic Cancer